Healthy Lungs California 2024: Engaging Providers & Health Systems on Lung Cancer Screening

Add to Calendar Healthy Lungs California 2024: Engaging Providers & Health Systems on Lung Cancer Screening 11/12/2024 8:00:00 AM 11/12/2024 4:30:00 PM America/Los_Angeles For More Details: https://ucla.cloud-cme.com/HealthyLungCA24 Description: Lung cancer and cancer screening experts will provide a one-day symposium on lung cancer screening. The full event will take place on Tuesday, 11/12 from 8:30am-4:00pm (registration 8:00-8:30am) at the Luskin Conference Center on UCLA's campus with live in-person/remote and enduring material options. The target audience is primary care providers/teams, radiologists, and health system managers/administrators who want t... UCLA Meyer & Renee Luskin Conference Center false MM/DD/YYYY


Date & Location
Tuesday, November 12, 2024, 8:00 AM - 4:30 PM, UCLA Meyer & Renee Luskin Conference Center, Los Angeles, CA

Overview

Lung cancer and cancer screening experts will provide a one-day symposium on lung cancer screening. The full event will take place on Tuesday, 11/12 from 8:30am-4:00pm (registration 8:00-8:30am) at the Luskin Conference Center on UCLA's campus with live in-person/remote and enduring material options. The target audience is primary care providers/teams, radiologists, and health system managers/administrators who want to learn about lung cancer screening and screening programs. This event considers the diversity of health systems with broad representation from panel members. Lunch is provided for in-person attendants.

The morning will include an introduction to the state of lung cancer screening in California, big-picture considerations for lung cancer screening programs (including key program elements and necessary human resources/leadership), and the creation of coordinated multidisciplinary pathways from screening to diagnosis to treatment.

The featured keynote speakers will be from 11:45am-1:30pm. The first half will focus on pragmatic lung cancer screening for primary care providers and teams, including risk factors, screening eligibility requirements, documentation, insurance coverage, discussing risks and benefits, and when to refer patients to specialist care (with Dr. Michael Ong). The first hour will also include a component of efficient and effective tobacco assessment and counseling. The second half will be tailored to radiologists and will focus on radiology's integral role in lung cancer screening (with Dr. Ashley Prosper) with topics including using LungRADS to read low-dose CTs, available templates and technology, like AI.

The afternoon will cover practical and logistical details on assessing the screen-eligible population, estimating the budgetary impact on a lung cancer screening program, sample workflows, maximizing your EHR and data capture for lung cancer screening. The event will conclude with policy gaps, the broader cancer context and looking to the future with new developments in lung cancer.


Registration

Fee: Free

Cancellation Policy
All cancellations must be submitted in writing via email to  [email protected] to ensure accurate tracking of registrants.

Course Recording
All registrants (live or virtual) will be provided the opportunity to review recorded sessions up to 3 weeks following the conference.
Viewing the recorded sessions after the live course are not approved for Continuing Education (CE) credit. 


Target Audience
Specialties - Diagnostic Radiology, Family Medicine, Health Care Administration, Leadership, and Management, Health Care Administration, Leadership, and Management*, Internal Medicine, Preventive Medicine, Public Health and General Preventive Medicine, Radiology
Professions - Administrator, Advanced Practice Nurse, Fellow/Resident, Nurse, Physician, Physician Assistant, Resident

Objectives
At the conclusion of this activity, learners will be able to:

  1. Describe updated lung cancer screening criteria
  2. Describe the burden of lung cancer in California and its inequities
  3. Discuss a balanced description of the risks and benefits of screening
  4. List 3 risk factors for lung cancer
  5. Name the LungRADS category that requires specialist referral
  6. Describe insurance coverage and various documentation requirements for lung cancer screening
  7. Utilize LungRADS to classify a lung nodule on low-dose CT
  8. Discuss how to estimate the screen-eligible number in your health system and the budgetary impact of a screening program
  9. Describe the components of a lung cancer screening program and necessary human resources
  10. Describe how the heterogeneity of health systems and their available resources may impact cancer screening program design
  11. Describe system-level barriers and facilitators to coordinated multidisciplinary diagnosis and treatment pathways
  12. List at least two strategies for harnessing technology to reduce manual labor/inputs in lung cancer screening
  13. Identify at least one policy option to improve equitable lung cancer screening, diagnosis, and/or treatment access

Accreditation
The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The David Geffen School of Medicine at UCLA designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

The California State Board of Registered Nursing
accepts courses approved for the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.


Credits
AMA PRA Category 1 Credits™ (6.25 hours), Non-Physician Attendance (6.25 hours)

Keywords: